ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,517, issued on May 20.
"Oral testosterone therapy" was invented by Nachiappan Chidambaram (Salt Lake City), Satish K. Nachaegari (Salt Lake City), Mahesh V. Patel (Salt Lake City) and Kilyoung Kim (Salt Lake City).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods and compositions for testosterone replacement therapy, especially for use in administration to hypogonadal males. The methods and compositions employ an untitrated dose dosing regimen that does not require titration or dose adjustments and that can provide a therapeutically effective amount of a testosterone ester, such as a non-undecanoate testosterone ester, while avoidi...